1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New York >
  6. 9 Meters Biopharma Acquires RDD Pharma

M&A Deal Summary

9 Meters Biopharma Acquires RDD Pharma

On November 7, 2019, 9 Meters Biopharma acquired life science company RDD Pharma

Acquisition Highlights
  • This is 9 Meters Biopharma’s 1st transaction in the Life Science sector.
  • This is 9 Meters Biopharma’s 1st transaction in the United States.
  • This is 9 Meters Biopharma’s 1st transaction in New York.

M&A Deal Summary
Date 2019-11-07
Target RDD Pharma
Sector Life Science
Buyer(s) 9 Meters Biopharma
Deal Type Add-on Acquisition
Advisor(s) Wyrick Robbins (Legal)

Target

RDD Pharma

New York, New York, United States
RDD Pharma Ltd. is a privately-held biopharmaceutical company focused on orphan and innovative therapies for gastrointestinal disorders. RDD Pharma Ltd. has two clinical-stage products that serve significant unmet needs. RDD-0315 is currently in Phase 2 development for the treatment of fecal incontinence in spinal cord injury patients. RDD-0315 has received Orphan Drug status in the E.U. and Fast Track designation in the U.S. RDD-1609 is being developed for the treatment of Pruritus Ani.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

9 Meters Biopharma

Raleigh, North Carolina, United States
Category Company
Sector Life Science
Employees10
Revenue 42M USD (2022)
DESCRIPTION

9 Meters Biopharma is a clinical-stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases. Innovate’s lead drug candidate, larazotide acetate, has a mechanism of action that renormalizes the dysfunctional intestinal barrier by decreasing intestinal permeability and reducing antigen traffickings, such as gliadin fragments in celiac disease, and bacterial toxins and immunogenic antigens in NASH. 9 Meters Biopharma is based in Raleigh, North Carolina.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New York M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal